HistoIndex Successfully Concludes Inaugural Breakfast Meeting In San Francisco!
The first HistoIndex Breakfast Meeting concluded successfully on 11 November 2018 at St. Regis San Francisco Hotel. An Affiliate Event under AASLD's The Liver Meeting®, the Breakfast Meeting provided the latest updates and facilitated discussions on how AI-based technology could significantly enhance liver biopsy assessment and identify efficacy trending data in NASH clinical trials. The event was attended by more than 50 guests from industry, pharmaceutical and academic institutions.
Prof. Detlef Schuppan
Director, Institute of Translational Immunology,
University Medical Center of the Johannes Gutenberg University, Mainz, Germany
A) The Future of Liver Biopsy in NASH Clinical Trials
Prof. Pierre Bedossa
Medical Director, LIVERPAT, Paris, France
Visiting Professor, Institute of Cellular Medicine, University of Newcastle, UK
B) Automated Fibrosis Quantification Used in NASH Clinical Trials
Prof. Stephen Harrison
Medical Director, Pinnacle Clinical Research, San Antonio, Texas, USA
Visiting Professor of Hepatology, Radcliffe Dept. of Medicine, University of Oxford, UK